| Jacqueline Verbaro, | |
|
1600 Haddon Ave, Camden, NJ 08103 | |
| (865) 757-3500 | |
| Not Available |
| Full Name | Jacqueline Verbaro |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 1600 Haddon Ave, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033612569 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Our Lady Of Lourdes Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Haddon Emergency Physicians Llc | 4082514229 | 19 |
| Central Jersey Urgent Care | 7618114323 | 67 |
News Archive
Bayer today announced results from a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase inhibitor, which demonstrated that treatment with regorafenib resulted in a 31 percent partial response rate and 50 percent stabilization rate in patients with metastatic renal cell carcinoma (RCC).
Like any back surgery, spinal stenosis treatment can be a significant and emotionally taxing moment in a person's life – which is why it is essential to ensure that it is effective the first time by trusting treatment to experts like Dr. Seyed M. Rezaian.
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.
Findings from two latest clinical trials reveal that a young child with ear infections recovers faster and more completely if doctors give antibiotics right away rather than waiting to see if the kid get better on his/her own. One of the studies was in the U.S. and one in Finland. Earlier it has been debated that for young children with middle ear infections or otitis media whether immediate antibiotic treatment was better than watchful waiting. Current treatment recommendations in the U.S., Canada, and Europe allow for a watch-and-wait approach to suspected middle ear infections in young children. Change is coming, predicts study leader Alejandro Hoberman, MD, of Children's Hospital of Pittsburgh.
For years, the official word on tanning has been … don't. Health organizations have driven home the message that the sun exposure needed to get a tan increases your chances of getting skin cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Verbaro, 1600 Haddon Ave, Camden, NJ 08103-3101 Ph: (856) 757-3500 | Jacqueline Verbaro, 1600 Haddon Ave, Camden, NJ 08103 Ph: (865) 757-3500 |
News Archive
Bayer today announced results from a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase inhibitor, which demonstrated that treatment with regorafenib resulted in a 31 percent partial response rate and 50 percent stabilization rate in patients with metastatic renal cell carcinoma (RCC).
Like any back surgery, spinal stenosis treatment can be a significant and emotionally taxing moment in a person's life – which is why it is essential to ensure that it is effective the first time by trusting treatment to experts like Dr. Seyed M. Rezaian.
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.
Findings from two latest clinical trials reveal that a young child with ear infections recovers faster and more completely if doctors give antibiotics right away rather than waiting to see if the kid get better on his/her own. One of the studies was in the U.S. and one in Finland. Earlier it has been debated that for young children with middle ear infections or otitis media whether immediate antibiotic treatment was better than watchful waiting. Current treatment recommendations in the U.S., Canada, and Europe allow for a watch-and-wait approach to suspected middle ear infections in young children. Change is coming, predicts study leader Alejandro Hoberman, MD, of Children's Hospital of Pittsburgh.
For years, the official word on tanning has been … don't. Health organizations have driven home the message that the sun exposure needed to get a tan increases your chances of getting skin cancer.
› Verified 9 days ago
Patrick Keenan, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-3150 | |
Emily A Delnero, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-546-8525 | |
Mrs. Amanda White, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave Fl 6, Camden, NJ 08103 Phone: 856-757-3500 Fax: 856-365-4088 | |
Ms. Shauna Milligan, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 403, Camden, NJ 08103 Phone: 856-342-2439 | |
Frank Pino, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737 | |
Ms. Dawnmarie Menniti, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-3150 | |
Mrs. Christie Morris, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 |